ERDHEIM-CHESTER DISEASE

Clinical trials for ERDHEIM-CHESTER DISEASE explained in plain language.

Never miss a new study

Get alerted when new ERDHEIM-CHESTER DISEASE trials appear

Sign up with your email to follow new studies for ERDHEIM-CHESTER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New drug cocktail trial targets tough cancers and rare diseases

Disease control Terminated

This early-phase study tested combinations of three drugs—bevacizumab, temsirolimus, and either valproic acid or cetuximab—in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find the safest dose and see how well the drugs w…

Matched conditions: ERDHEIM-CHESTER DISEASE

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 02, 2026 11:39 UTC

ERDHEIM-CHESTER DISEASE

Get alerted when new ERDHEIM-CHESTER DISEASE trials appear

New drug cocktail trial targets tough cancers and rare diseases